I wonder if the new strains are convoluting the data and that is why the longer process.
Considering we are selling a statistical model that will guide the individual about their risk, perhaps with new strains the margin of error has become too high without further incorporating the fresh data.
- Forums
- ASX - By Stock
- Massive re rate coming for GTG in 2021
I wonder if the new strains are convoluting the data and that is...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GTG (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.671M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online